PTEN loss is reported in 65% of MCL patients displaying increased cyclin D1 translation (115) and it correlates with the constitutive activation of Akt/mTORC1 signaling in MCL patients and in human MCL cell lines (116). This evidence concerns the gene AKT1 and mantle cell lymphoma.